Here are 13 key notes on spine and orthopedic device companies.
Amedica named B. Sonny Bal, MD, JD, MBA, chairman of its board of directors.
Cesca Therapeutics presented findings from a case study highlighting the potential clinical benefit and cost savings of its SurgWerks-CLI cell therapy to CMS.
Exactech Director Albert H. Burstein sold 8,852 shares of the company's stock on Monday, Aug. 25.
The first surgery using the FLXfit from Expanding Orthopedics was performed in France.
Gabelli will now cover Globus Medical, a spine-focused medical device company.
LDR CEO Christophe Lavigne sold 25,000 shares of the company's stock on the open market yesterday.
Medtronic gained Food and Drug Administration clearance for the SHILLA Growth Guidance System for patients with severe early-onset spinal deformities.
The company also acquired Sapiens Steering Brain Stimulation for around $200 million in an all-cash transaction.
Spine Pain Management added Peter Dalrymple to the board of directors.
The company also appointed David Spencer as its CIO.
Rudy Padua, PhD, recently joined St. Teresa Medical as director of clinical affairs to oversee the ORTHOCLOT human trials.
Surgical Frontiers closed on a $7 million fund for the company's future growth.
A new Zacks report upgrades Symmetry Medical to an "outperform" rating.
More articles on devices:
St. Teresa Medical names Dr. Rudy Padua director of clinical affairs
Surgical Frontiers closes $7M funding: 5 things to know
Medtronic launches severe pediatric spinal deformity growth guidance system